Switching to E-cigarettes or quitting smoking after PCI was associated with lower MACE risk (HR 0.82 for switchers, HR 0.87 for quitters) compared to continued smoking.
Does switching to electronic cigarettes or quitting smoking reduce major adverse cardiac events in smokers who underwent percutaneous coronary intervention compared to continued combustible cigarette use?
Switching to electronic cigarettes or completely quitting smoking after PCI is associated with a significantly lower risk of major adverse cardiac events compared to continuing combustible cigarette use.
Absolute Event Rate: 0% vs 0%
Abstract Background and Aims Despite the increasing popularity of electronic cigarettes (E-cigarettes), the prognostic impact of switching to E-cigarettes in smokers with coronary artery disease who have undergone percutaneous coronary intervention (PCI) remains unclear. Methods Using a nationwide cohort from the Korean National Health Insurance database, 17 973 adults (≥20 years) identified as smokers (based on a health screening examination within 3 years before PCI) who underwent health screening within 3 years after PCI were enrolled to determine changes in smoking habits. Patients were classified as continued combustible cigarette users, successful quitters, or switchers to E-cigarettes. The group switching to E-cigarettes was further divided into dual users (using both combustible and E-cigarettes) and those exclusively using E-cigarettes. Primary outcomes included major adverse cardiac events (MACEs), a composite of all-cause death, spontaneous myocardial infarction, and repeat revascularization. Results Among the total population, 8951 patients (49.8%) continued using combustible cigarettes, 1694 (9.4%) were switched to E-cigarettes, and 7328 (40.7%) successfully quit smoking after PCI. During a median follow-up of 2.4 years, the cumulative incidence of MACE was lower among E-cigarette switchers (10%) or quitters (13.4%) than among continued combustible cigarette users (17%). When continued combustible cigarette users were used as the reference, the multivariable-adjusted hazard ratios with 95% confidence intervals for MACE were 0.82 (0.69–0.98) for switchers to E-cigarettes and 0.87 (0.79–0.96) for successful quitters. Compared with dual users, entirely switching to E-cigarettes was associated with a significantly lower MACE risk (hazard ratio 0.71; 95% confidence interval 0.51–0.99). Conclusions Among smokers who underwent PCI for coronary artery disease, switching to E-cigarette use (particularly complete transition) or quitting smoking was associated with reduced MACE risk than with continued combustible cigarette use. Clinical Trial Registration ClinicalTrials.gov NCT06338761
Kang et al. (Mon,) reported a other. Switching to E-cigarettes or quitting smoking after PCI was associated with lower MACE risk (HR 0.82 for switchers, HR 0.87 for quitters) compared to continued smoking.